Opdivo No Longer FDA-Approved for Small Cell Lung Cancer
In 2018, the FDA granted accelerated approval to Opdivo for SCLC based on data from the phase 1/2 CheckMate -032 trial.
Oncology Information Center
Smoking Risks for Colorectal Cancer to Discuss With Patients
Smoking is consistently seen as a risk for various cancers, and in recent years it has been connected to colorectal cancer in particular.
New Mammogram-Based Measures Improve Breast Cancer Prediction
New mammogram-based risk measures based on brightness and texture improve breast cancer risk prediction beyond an established measure of mammographic density.
Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
UV Exposure Not Linked to Risk for Melanoma in Skin of Color
Among people with skin of color, ultraviolet light exposure may not be an important risk factor for melanoma.
Kidney Cancer Stage Migrated Downward in Low Income Patients After ACA
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
Prior Radiation Linked to Worse Survival in Bladder Cancer Cases
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.
Inappropriate Imaging of Low-Risk Prostate Cancer Patients Continues
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Top November 2020 FDA Approvals
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Medicaid Expansion Tied to Increased Detection of Early Cancers
Medicaid expansion under the Affordable Care Act was linked to an increase in early-stage cancer diagnoses in the first year after expansion.
Top October 2020 FDA Approvals
The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.
Understanding the Stigma Experienced by Patients With Prostate Cancer
Interview study identifies men’s perception and concerns related to their prostate cancer journey.
Telehealth Disparity Seen in Cancer Care
Black and Hispanic patients with cancer used telehealth less often than White patients during the COVID-19 pandemic in New York City.
Analysis Identified Patient-Reported Outcomes Associated With Whole-Breast Radiotherapy
Review of patient-reported outcomes identified posttreatment symptoms ranging in severity from pain to bother in women undergoing radiotherapy for breast cancer.
Nurse Practitioner Role Improves Radiation Oncology Follow-Up Care, Patient Experience
A posttreatment program demonstrated that nurse practitioner-led follow-up visits can be an essential component of radiation therapy.
Can Earlier Mammographic Screenings Affect Mortality Rates?
A study in The Lancet Oncology examined the age when breast cancer screenings commonly begin, and whether researchers feel it should be sooner.
COVID-19, SARS-CoV-2 Infection Phenotypes Vary With Different Tumor Subtypes
Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
A deep learning model based on chest radiograph images and electronic medical record data shows promise for smokers at high risk for lung cancer
MASCC Survey Identifies Research, Development Goals for Cancer Survivorship Care
A survey of MASCC clinician members identified 3 areas for further research and development to improve survivorship care plans for cancer survivors.
ASTRO Issues First Guideline on Radiation Therapy for Cervical Cancer
There is strong evidence supporting the use of radiation therapy for nonmetastatic cervical cancer.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Oncology Information Center
